The current mpox outbreak has exposed some serious gaps in Africa’s health systems—limited disease surveillance, testing delays and underfunded labs. But the problem doesn’t stop there. These...
World + 1 more
Africa Centres for Disease Control and Prevention (Africa CDC) Updates
Search
Refine the list with filters
Search helpList
Showing 1 - 20 of 79 results
World + 1 more
Egypt’s Hepatitis Programme Becomes a Model for African Countries
Egypt’s Hepatitis Programme, also known as the “100 Million Healthier Lives” campaign has become a benchmark for African countries. The nationwide effort has led the country to become the first in...
Mpox Vaccination Programme Gets off the Ground in Nigeria
On November 18, 2024, Nigeria launched its mpox vaccination campaign, targeting healthcare workers and individuals with weakened immune systems in hospitals across the Federal Capital Territory (FCT)...
Rwanda + 1 more
Statement from Africa CDC on Rwanda and Senegal National Regulatory Authorities Achieving WHO Maturity Level 3
Addis Ababa, 9 December 2024 – Africa CDC congratulates the Rwanda Food and Drug Regulatory Authority (Rwanda FDA) and the Senegalese Pharmaceutical Regulatory Agency (ARP) on achieving World Health...
National Borders a Critical Frontline in Containing Deadly Infections
National borders are not just geographical demarcations but critical frontlines in the fight against infectious diseases, especially deadly infections like COVID-19, mpox and marburg. Thus, in the...
Protecting Kids: Mpox Guidelines for Schools
The safety of children is a top concern for parents and school authorities in the current mpox outbreak, as those under 15 face elevated risks, particularly in the hardest-hit Northwestern and...
World + 1 more
Singapore’s Health Ministry and Africa CDC Announce Joint Efforts to Tackle the Mpox Outbreak
Singapore, Addis Ababa, 15 November, 2024 – To strengthen the Africa Centres for Disease Control and Prevention’s (Africa CDC) capacity for enhanced mpox case management, the Ministry of Health,...
Mpox Testing Strategy - November 2024
1. BACKGROUND AND RATIONALE Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was...
A New Digital Health Platform for Africa
As the use of digital tools for effective healthcare delivery gradually takes foothold in Africa, the Africa CDC has unveiled a new platform that caters for differing needs in technology, including...
DR Congo + 16 more
WHO, Africa CDC support 17 countries to develop mpox vaccination plans
09 November 2024 Brazzaville – World Health Organization (WHO) and Africa Centres for Disease Control and Prevention (Africa CDC) experts gathered in Brazzaville this week with country...
Smallpox Drug in Clinical Trials for Treating Mpox in Africa
A drug currently approved for smallpox in the U.S. will undergo clinical trials to treat patients infected by the Mpox viruswho are at risk of severe complications in the Democratic Republic of Congo...
Strengthening Immunisation in Eswatini
Four years after Eswatini adopted five-dose Measles-Rubella vaccine vials for routine immunisation, Africa CDC joined WHO-AFRO, Eswatini’s Ministry of Health, and UNICEF to assess this pivotal shift...
DR Congo + 8 more
Des doses de vaccin ont été allouées aux neuf pays africains les plus durement touchés par la recrudescence de la mpox (variole simienne)
Communiqué de presse conjoint des CDC-Afrique, de la CEPI, de l’Alliance Gavi, de l’UNICEF et de l’OMS 6 novembre 2024 Communiqué commun Addis-Abeba/Genève/New York/Oslo Le mécanisme d’accès et...
DR Congo + 8 more
Vaccine doses allocated to 9 African countries hardest hit by mpox surge: Joint press release Africa CDC, CEPI, Gavi, UNICEF, WHO
Addis Ababa/Geneva/New York/Oslo -- The Access and Allocation Mechanism (AAM) for mpox has allocated an initial 899 000 vaccine doses for 9 countries across the African region that are hit hard by...
Statement | SARS-COV-2 XEC Sub-variant, 4 November 2024
Situation Summary COVID-19 continues to spread globally and is dominated by descendant sub-variants of the SARS-COV-2 Omicron Variant. The main sub-variants of omicron circulating currently around...
Antimicrobial Resistance Surveillance Guidance for the African Region
1. BACKGROUND 1.1 ANTIMICROBIAL RESISTANCE, ITS PUBLIC HEALTH RELEVANCE AND BURDEN IN AFRICA Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are...
Statement on Antigen Rapid Tests for Mpox Diagnosis, 30 October 2024
No Antigen Rapid Diagnostic Test (RDT) has demonstrated the minimum requirement for mpox testing. On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the...
African Vaccine Manufacturing Mapping | Supply and Demand Landscape
This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International Annual General Meeting in October 2024, describes updated results from a study to assess the current...
Strengthening Cross-Border Surveillance and Information Sharing in Africa (July 2024)
Executive Summary The African Union Member States (AU MS) face significant health threats, particularly infectious diseases, due to its overstretched public health systems and infrastructure. Despite...
World + 2 more
Mpox Epidemic in Africa (01 September-29 September 2024)
Executive Summary Summary of major developments during the reporting period (e.g., significant outbreaks, policy changes, vaccination campaigns, etc.). • Africa CDC and WHO established a Technical...